Bente Glintborg

Bente Glintborg

Clinical Associate Professor

Member of:

  • Internal Medicine: Rheumatology


  1. 2019
  2. Published

    Pain Mechanisms and Ultrasonic Inflammatory Activity as Prognostic Factors in Patients With Psoriatic Arthritis: A Prospective Cohort Study

    Højgaard, P., Ellegaard, K., Nielsen, S. M., Christensen, R., Guldberg-Møller, J., Ballegaard, C., Dreyer, L., Mease, P., de Wit, M., Skov, Lone, Glintborg, Bente, Bliddal, Henning, Bartels, E. M., Amris, K. & Kristensen, Lars Erik Vølund, Jun 2019, In: Arthritis Care & Research. 71, 6, p. 798-810 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Comparing patient-reported outcomes entered at home versus at hospital, and testing touch screens for initial recruitment to scientific trials in arthritis patients

    Secher, A. E., Glintborg, Bente, Gudbergsen, Henrik Rindel, Krogh, N. S., Sørensen, I. J., Jensen, D. V., Christensen, R., Skougaard, M., Pedersen, P. L. & Hetland, Merete Lund, 4 May 2019, In: Scandinavian Journal of Rheumatology. 48, 3, p. 178-184 7 p.

    Research output: Contribution to journalLetterResearchpeer-review

  4. Published

    Impact of red meat, processed meat and fibre intake on risk of late-onset chronic inflammatory diseases: prospective cohort study on lifestyle factors using the Danish 'Diet, Cancer and Health' cohort (PROCID-DCH): protocol

    Rasmussen, N. F., Rubin, K. H., Stougård, Maria, Tjønneland, Anne, Stenager, E., Hetland, Merete Lund, Glintborg, Bente, Bygum, A. & Andersen, V., 30 Mar 2019, In: BMJ Open. 9, 3, e024555.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Extremely poor patient-reported outcomes are associated with lack of clinical response and decreased retention rate of tumour necrosis factor inhibitor treatment in patients with axial spondyloarthritis

    Krabbe, S., Glintborg, Bente, Østergaard, Mikkel & Hetland, Merete Lund, Mar 2019, In: Scandinavian Journal of Rheumatology. 48, 2, p. 128-132 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Comparative Effectiveness of Certolizumab Pegol, Abatacept, and Biosimilar Infliximab in Patients With Rheumatoid Arthritis Treated in Routine Care: Observational Data From the Danish DANBIO Registry Emulating a Randomized Trial

    Grøn, K. L., Glintborg, Bente, Nørgaard, M., Mehnert, F., Østergaard, Mikkel, Dreyer, L., Krogh, N. S., Bjørner, Jakob Bue & Hetland, Merete Lund, 2019, In: Arthritis & Rheumatology. 71, 12, p. 1997-2004 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    DIRECT COMPARISON OF CERTOLIZUMAB PEGOL, ABATACEPT AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN ROUTINE CARE. OBSERVATIONAL DATA FROM THE DANISH DANBIO REGISTRY ANALYZED LIKE A RANDOMIZED CLINICAL TRIAL

    Grøn, K., Glintborg, Bente, Nørgaard, M., Mehnert, F., Stergaard, M., Dreyer, L., Krogh, N. S., Bjørner, Jakob Bue & Hetland, Merete Lund, 2019, In: Annals of the Rheumatic Diseases. 78, Suppl 2, p. 1391-1391 SAT0595.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  8. Published

    Does a mandatory non-medical switch from originator to biosimilar etanercept lead to increase in healthcare use and costs?

    Glintborg, Bente, Ibsen, R., Bilbo, R. E. Q., Hetland, Merete Lund & Kjellberg, J., 2019, In: RMD Open. 5, 2, 9 p., e001016.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    OVERALL INFECTION RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ABATACEPT, RITUXIMAB AND TOCILIZUMAB: AN OBSERVATIONAL COHORT STUDY

    Grøn, K., Glintborg, Bente, Mehnert, F., Østergaard, Mikkel, Dreyer, L., Nørgaard, M., Krogh, N. S. & Hetland, Merete Lund, 2019, In: Annals of the Rheumatic Diseases. 78, Suppl 2, p. 630 THU0667.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  10. Published

    Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

    Canet, L. M., Sánchez-Maldonado, J. M., Cáliz, R., Rodríguez-Ramos, A., Lupiañez, C. B., Canhão, H., Martínez-Bueno, M., Escudero, A., Segura-Catena, J., Sorensen, S. B., Hetland, M. L., Soto-Pino, M. J., Ferrer, M. A., García, A., Glintborg, B., Filipescu, I., Pérez-Pampin, E., González-Utrilla, A., Nevot, M. Á. L., Conesa-Zamora, P. & 10 others, Broeder, A. D., De Vita, S., Jacobsen, S. E. H., Collantes-Estevez, E., Quartuccio, L., Canzian, F., Fonseca, J. E., Coenen, M. J. H., Andersen, V. & Sainz, J., 2019, In: The Pharmacogenomics Journal. 19, 1, p. 83-96 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    RISK OF HOSPITALIZED INFECTION IN PATIENTS WITH CHRONIC INFLAMMATORY ARTHRITIS TREATED WITH BIOLOGICAL DRUGS: A MATCHED COHORT STUDY

    Krabbe, S., Grøn, K. L., Glintborg, Bente, Mehnert, F., Jarbøl, D. E., Østergaard, Mikkel & Hetland, Merete Lund, 2019, In: Annals of the Rheumatic Diseases. 78, Suppl 2, p. 214 OP0266.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

Previous 1 2 Next

ID: 212553036